{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:44:37Z","timestamp":1792817077549,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/ard-2022-223528","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T18:20:20Z","timestamp":1674757220000},"page":"594-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-6947","authenticated-orcid":false,"given":"Kevin L","family":"Winthrop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6103-7056","authenticated-orcid":false,"given":"John D","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-0457","authenticated-orcid":false,"given":"Philip J","family":"Mease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-4671","authenticated-orcid":false,"given":"Dimitrios T","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9362","authenticated-orcid":false,"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-946X","authenticated-orcid":false,"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-7311","authenticated-orcid":false,"given":"Stefan","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2108-0030","authenticated-orcid":false,"given":"Daniel","family":"Aletaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-7520","authenticated-orcid":false,"given":"Tom W J","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard E","family":"Voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M","family":"Gravallese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferry C","family":"Breedveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef S","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2022-223528_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223528_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jre.12002","article-title":"Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva","volume":"48","author":"Harvey","year":"2013","journal-title":"J Periodontal Res"},{"key":"10.1136\/ard-2022-223528_bib4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.34344","article-title":"Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?","volume":"64","author":"Demoruelle","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223528_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (treat earlier): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"key":"10.1136\/ard-2022-223528_bib7","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/annrheumdis-2016-209991","article-title":"Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands","volume":"76","author":"van Zanten","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib8","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"key":"10.1136\/ard-2022-223528_bib9","article-title":"Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis","author":"Zhang","year":"2022","journal-title":"bioRxiv"},{"key":"10.1136\/ard-2022-223528_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1136\/ard-2022-223528_bib12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-223528_bib13","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/rheumatology\/kez049","article-title":"Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis","volume":"58","author":"Hensor","year":"2019","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223528_bib14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.40878","article-title":"Histologic and transcriptional evidence of subclinical synovial inflammation in patients with rheumatoid arthritis in clinical remission","volume":"71","author":"Orange","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223528_bib15","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.22190","article-title":"Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression","volume":"54","author":"Brown","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223528_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.22541","article-title":"Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy","volume":"67","author":"Ranganath","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223528_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.11481","article-title":"Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission","volume":"50","author":"Molenaar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223528_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.40428","article-title":"Identification of three rheumatoid arthritis disease subtypes by machine learning integration of synovial histologic features and RNA sequencing data","volume":"70","author":"Orange","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223528_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211057975","article-title":"Axial involvement in psoriatic arthritis cohort (axis): the protocol of a joint project of the assessment of spondyloarthritis International Society (ASAS) and the group for research and assessment of psoriasis and psoriatic arthritis (grappa)","volume":"13","author":"Poddubnyy","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1136\/ard-2022-223528_bib20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.semarthrit.2021.06.006","article-title":"Axial involvement in psoriatic arthritis: an update for rheumatologists","volume":"51","author":"Poddubnyy","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2022-223528_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/BOR.0000000000000720","article-title":"Mhc class I associations beyond HLA-B27: the peptide binding hypothesis of psoriatic arthritis and its implications for disease pathogenesis","volume":"32","author":"Winchester","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 11","key":"10.1136\/ard-2022-223528_bib22","first-page":"S64","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223528_bib23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/annrheumdis-2018-214280","article-title":"Unmet need in rheumatology: reports from the targeted therapies meeting 2018","volume":"78","author":"Winthrop","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on\u00a0bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2022-223528_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/annrheumdis-2018-213654","article-title":"Why did IL-23p19 inhibition fail in as: a tale of tissues, trials or translation?","volume":"78","author":"Siebert","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of Anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2022-223528_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2018.08.025","article-title":"A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int"},{"key":"10.1136\/ard-2022-223528_bib30","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (Aurora 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"10.1136\/ard-2022-223528_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized Immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"10.1136\/ard-2022-223528_bib32","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223528_bib33","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/annrheumdis-2021-222069","article-title":"Cross-Species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis","volume":"81","author":"Frangou","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib34","doi-asserted-by":"crossref","first-page":"860726","DOI":"10.3389\/fimmu.2022.860726","article-title":"Molecular taxonomy of systemic lupus erythematosus through data-driven patient stratification: molecular Endotypes and Cluster-Tailored drugs","volume":"13","author":"Garantziotis","year":"2022","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2022-223528_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/annrheumdis-2019-215782","article-title":"Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus","volume":"79","author":"Grigoriou","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib36","doi-asserted-by":"crossref","first-page":"25222","DOI":"10.1073\/pnas.1908576116","article-title":"Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus","volume":"116","author":"Mistry","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2022-223528_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/annrheumdis-2018-214379","article-title":"Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity","volume":"78","author":"Panousis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib38","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1038\/s41598-019-51616-9","article-title":"Differential treatments based on drug-induced gene expression signatures and longitudinal systemic lupus erythematosus stratification","volume":"9","author":"Toro-Dom\u00ednguez","year":"2019","journal-title":"Sci Rep"},{"key":"10.1136\/ard-2022-223528_bib39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-223528_bib40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-223528_bib41","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","article-title":"Mapping systemic lupus erythematosus heterogeneity at the single-cell level","volume":"21","author":"Nehar-Belaid","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-223528_bib42","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3899\/jrheum.181054","article-title":"Adaptive trial designs in rheumatology: report from the OMERACT special interest group","volume":"46","author":"Pickles","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223528_bib43","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a lupus low disease activity state (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223528_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/annrheumdis-2018-214502","article-title":"Derivation and validation of the SLE disease activity score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity","volume":"78","author":"Jesus","year":"2019","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724084577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724084577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2022-223528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:24:27Z","timestamp":1737437067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724084577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0003496724084577"],"URL":"https:\/\/doi.org\/10.1136\/ard-2022-223528","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2022-223528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}